Actuate Therapeutics, Inc. ACTU Q4 2025 Annual earnings

FAQ

When did Actuate Therapeutics, Inc. report Q4 2025 earnings?

Actuate Therapeutics, Inc. (ACTU) reported Q4 2025 earnings on March 26, 2026 before market open.

What were Actuate Therapeutics, Inc.'s Q4 2025 revenue and EPS?

Actuate Therapeutics, Inc. reported eps of $-0.18 for Q4 2025.

Did Actuate Therapeutics, Inc. beat estimates in Q4 2025?

EPS beat the consensus estimate of $-0.24 by $0.06.

How did Actuate Therapeutics, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 45.5% from $-0.33.

Where can I find Actuate Therapeutics, Inc.'s Q4 2025 SEC filings?

You can read the 10-K periodic report (0001683168-26-002257) directly on SEC EDGAR. The filing index links above go to sec.gov.